Praetego Inc.
Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology.
Company Location
68 T.W. Alexander Drive
Research Triangle Park
NC
27709
P.O. Box 13628
Research Triangle Park
NC
27709
Phone
County
Region
Company Details
Company type
Year founded
2017
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products under development
PTG-630 (early intervention of Alzheimer's), PTG-670